Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine

► Newborn screening for Tyr-I is mandatory before life-threatening symptoms occur. ► Current protocols are time-consuming, and include cancerogenic reagents. ► We evaluated a novel assay without the need of hazardous reagents.